Blair William & CO Intellia Therapeutics, Inc. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Blair William & CO holds 10,307 shares of NTLA stock, worth $258,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,307

Previous 10,250 0.56%

Holding current value

$258,499

Previous $312,000 9.29%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$23.82 - $32.8 $1,357 - $1,869	57 Added 0.56%	10,307 $283,000
Q4 2023 Feb 12, 2024	BUY	$23.16 - $32.34 $23,160 - $32,340	1,000 Added 10.81%	10,250 $312,000
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $69,160 - $92,060	2,000 Added 27.59%	9,250 $377,000
Q1 2023 May 12, 2023	SELL	$33.3 - $44.82 $3,662 - $4,930	-110 Reduced 1.49%	7,250 $270,000
Q4 2022 Feb 10, 2023	SELL	$33.21 - $62.69 $105,541 - $199,228	-3,178 Reduced 30.16%	7,360 $256,000

Q3 2022 Nov 09, 2022	BUY	$53.92 - $71.7 $9,597 - $12,762	178 Added 1.72%	10,538 $590,000
Q2 2022 Aug 10, 2022	SELL	$38.49 - $76.21 $76 - $152	-2 Reduced 0.02%	10,360 $536,000
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $64,097 - $130,889	1,100 Added 11.88%	10,362 $753,000
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $15,315 - $21,030	152 Added 1.67%	9,262 $1.1 Million
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $46,590 - $83,680	1,000 Added 12.33%	9,110 $731,000
Q4 2020 Feb 09, 2021	BUY	$18.83 - $63.53 $152,711 - $515,228	8,110 New	8,110 $441,000
Q4 2019 Feb 13, 2020	SELL	$10.43 - $17.67 $205,783 - $348,629	-19,730 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$13.88 - $18.41 $35,116 - $46,577	-2,530 Reduced 11.37%	19,730 $323,000
Q1 2019 May 14, 2019	BUY	$12.79 - $17.62 $2,558 - $3,524	200 Added 0.91%	22,260 $380,000
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $137,363 - $327,187	12,060 Added 120.6%	22,060 $301,000
Q3 2018 Nov 13, 2018	SELL	$25.78 - $32.6 $154,680 - $195,600	-6,000 Reduced 37.5%	10,000 $286,000
Q2 2018 Aug 13, 2018	BUY	$20.02 - $30.79 $320,320 - $492,640	16,000 New	16,000 $438,000

Others Institutions Holding NTLA

# of Institutions

319

Shares Held

89.2M

Call Options Held

686K

Put Options Held

599K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.91B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account